Barcelona Appeal Court reverses first instance judgment that had found apixaban patent to be invalid

Source: Pharma – Kluwer Patent Blog · Published: 2024-07-23

This morning, the Barcelona Appeal Court has announced a judgment of 18 July 2024, reversing the judgment of 15 January 2024 from Commercial Court number 4 of Barcelona, which had found patent EP 1,427,415 (&#8220;EP &#8216;415&#8221;), protecting apixaban, to be invalid. The main highlights of the decision may be summarized as follows: The first interesting... <div class="more-container"><a class="more-link" href="https://patentblog.kluweriplaw.com/2024/07/23/barcelona-appeal-court-reverses-first-instance-judgment-that-had-found-apixaban-patent-to-be-invalid/" itemprop="url" data-wpel-link="internal">Continue reading</a></div>